Skip to content

Drug interactions

Irinotecan + Pacritinib

Severity: Moderate

Irinotecan and Pacritinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pacritinib inhibits BCRP and may increase SN-38 exposure, raising irinotecan toxicity. Pacritinib also causes diarrhoea, adding to the risk.

What this interaction means in plain words

Irinotecan and Pacritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Irinotecan belongs to Oncology; Pacritinib belongs to Oncology.

Evidence level: Low

Why it happens

BCRP inhibition reduces efflux of SN-38, with additive gastrointestinal effects.

What to do

Monitor for diarrhoea and neutropenia, and reduce irinotecan dose if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Pacritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Pacritinib?

MediHelp rates the interaction as moderate. Irinotecan and Pacritinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pacritinib inhibits BCRP and may increase SN-38 exposure, raising irinotecan toxicity. Pacritinib also causes diarrhoea, adding to the risk.

How serious is the interaction between Irinotecan and Pacritinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for diarrhoea and neutropenia, and reduce irinotecan dose if toxicity develops.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in